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Cloning and Characterization of the Canine Photoreceptor Specific Cone-
Rod Homeobox (CRX) Gene and Evaluation as a Candidate for Early
Onset Photoreceptor Diseases in the Dog
Abstract
Purpose: The cone-rod homeobox protein (CRX) is a member of the homeodomain-containing protein
family expressed in the retinal photoreceptors and pinealocytes; it is involved in the regulation of the
coordinate expression of multiple photoreceptor specific genes during retinal development. Mutations in the
CRX gene are causally associated with retinal degeneration phenotypes in man. To clone the full length
cDNA, characterize the genomic organization of canine CRX, map the gene in a radiation hybrid (RH) panel,
and evaluate it as a candidate for canine inherited retinal degenerations.
Methods: cDNA representational difference analysis (RDA) was done using normal and cone degeneration
(cd) affected retinas. Exonic primers designed from consensus sequences of mammalian CRX cDNA were
used to amplify and sequence dog genomic DNA. Canine specific primers were used for RH mapping of CRX
on the RH3000 cell line. Linkage, sequencing and/or mapping the disease locus was used to evaluate CRX as
a disease associated candidate gene.
Results: The gene comprises three exons and two introns and codes for a transcript with a 900 bp open
reading frame (ORF). In agreement with human map data, RH mapping placed canine CRX on the proximal
end of CFA1, in a region of synteny with HSA19q13-q13.3. Based on RH mapping, meiotic linkage or
sequencing data, we excluded CRX as the cause of canine early onset photoreceptor degenerations affecting
Alaskan malamutes (cd), collies (rod-cone dysplasia 2, rcd2), American Staffordshire terriers, and Tibetan
terriers.
Conclusions: Canine CRX has a high level of nucleotide and amino acid sequence identity with ortholgous
sequences reported for other species. The gene is excluded from causal association with 4 early onset
photoreceptor diseases affecting cones (cd) or rods and cones (rcd2, PRA in American Staffordshire terriers,
and Tibetan terriers).
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The cone-rod homeobox protein (CRX) is a member of
the homeodomain-containing protein family, and is expressed
in retinal photoreceptors and pinealocytes [1,2]. As a transcrip-
tion factor, CRX is involved in vertebrate eye development
and plays an important role in gene expression. CRX binds to
conserved sites of several photoreceptor specific genes in the
retina, and transactivates their expression during photorecep-
tor differentiation and maturation. Microarray analysis of reti-
nas from wild type and CRX-deficient mice has indicated that
the expression of 10 out of 17 differentially expressed genes
controlled by CRX are photoreceptor specific or photorecep-
tor enriched. All of these target genes contain consensus CRX-
binding elements [3]. Furthermore, both the leucine zipper
domain of NRL (neural retinal leucine zipper) and the DBD2
and DBD3 domains of HMG I (Y) (non-histone chromosomal
proteins high mobility group I (Y)) have been observed to act
synergistically with CRX in the enhancement of expression
of some photoreceptor specific genes. These interactions are
crucial, for example, in the regulation of rhodopsin expres-
sion [4,5].
Because of its critical role in the early stages of photore-
ceptor development, CRX is an excellent candidate gene for
early onset retinal diseases [1]. This has been confirmed by
the identification of mutations that result in cone-rod dystro-
phy [6,7] and Lebers congenital amaurosis [8-10]. In addi-
tion, a wide range of clinical retinal phenotypes have been
associated with mutations in this gene [11-15].
The impetus for the present study arose from an ongoing
project to identify and enable evaluation of candidate genes
for the large number of inherited canine photoreceptor disor-
ders for which causes have not yet been identified. To this end
we identified canine CRX (cCRX) as a specifically attractive
candidate for cloning and evaluation. In parallel, we under-
took to identify other potential candidate genes using Repre-
sentational Difference Analysis (RDA). RDA was used to find
genes expressed differentially between normal canine retinas
and retinas affected with cone degeneration (cd). One of the
clones identified by RDA turned out to be the cCRX cDNA.
We thus report here the cloning of cCRX by two different but
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complementary strategies, the characterization of its genomic
organization, and its exclusion as the cause of canine cd in
Alaskan malamutes, rod cone dysplasia type 2 (rcd2) in col-
lies, and two different forms of early onset progressive retinal
atrophy (PRA) affecting the American Staffordshire terrier and
the Tibetan terrier, respectively.
METHODS
Animals, pedigrees and samples:  Blood samples were ob-
tained from privately owned Tibetan terrier dogs affected with
an autosomal recessive form of progressive retinal atrophy
(PRA). This form of PRA is clinically evident by 1-1.5 years
and progresses to complete blindness at a young age [16].
Blood and tissue samples from all other dogs studied were
obtained from the Retinal Disease Studies Facility (RDSF)
colony maintained under the sponsorship of NEI/NIH grant
EY-06855 (see below). Genomic DNA was isolated from
citrated blood samples either by standard phenol/chloroform
extraction, or a rapid protocol described previously [17].
To enable identification of potential retinal degeneration
genes by RDA, normal canine retinas and retinas from cd af-
fected dogs [18-20] were obtained from the RDSF colony.
Blood, retinal and other tissue samples were also obtained from
2 other strains of dogs from the RDSF colony. Each such strain
represented a different canine pedigree segregating a pheno-
typically distinct retinal disease. The rcd2 strain segregates an
autosomal recessive rod-cone defect originally derived from
collie dogs [21,22]. The other strain segregates a different
autosomal recessive early onset retinal degeneration derived
from the American Staffordshire terrier breed. The latter dis-
ease is as yet incompletely characterized, but affected animals
have severe visual impairment by 6 months of age which
progresses rapidly to total blindness (Acland and Aguirre,
unpublished). All procedures involving animals were done in
accordance with the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research.
Isolation of RNA, cDNA synthesis, and cDNA Represen-
tational Difference Analysis (RDA):  Total RNA was isolated
from normal and cd affected canine retinas, both samples from
animals 2 years of age, using RNAzol B (Tel-Test Inc.,
Friendswood, TX). At 2 years of age, the cd affected retinas
would have nearly complete loss of cones, thus enriching for
cone transcripts that would be expressed in the normal retina.
Poly(A)+ RNAs were fractionated from total RNA by two
successive rounds on oligo(dT)-cellulose columns (Amersham
Pharmacia Biotech Inc., Piscataway, NJ). First strand cDNA
synthesis was performed with Super Script II reverse tran-
scriptase (Invitrogen, Carlsbad, CA) using 2 µg of mRNA and
1 µg of oligo(dT) primer. Then the first strand cDNA was used
as a template to create the second strand cDNA, as described
in the manufacturer’s protocol (Life Technologies Inc.,
Gaithersburg, MD).
Generation of fragments for RDA was carried out accord-
ing to the protocol of Hubank and Schatz [23], and based on
genomic representational difference analysis [24]. Double
stranded cDNA (4 µg) was digested with DpnII and amplified
cDNA fragments (amplicons) were obtained using different
sets of primers: R-Bgl-12 (GAT CTG CGG TGA), R-Bgl-24
(AGC ACT CTC CAG CCT CTC), J-Bgl-12 (GAT CTG TTC
ATG), J-Bgl-24 (ACC GAC GTC GAC TAT CCA TGA ACA),
N-Bgl-12 (GAT CTT CCC TCG), and N-Bgl-24 (AGG CAA
CTG TGC TAT CCG AGG GAA). Three rounds of subtrac-
tive hybridization were performed and the RDA products were
digested with DpnII and ligated to pBluescript KS II+
(Stratagene, La Jolla, CA). Sequence of the cDNA inserts was
determined using the Thermo Sequenase II dye terminator
cycle sequencing kit (Amersham Pharmacia Biotech Inc.,
Piscataway, NJ).
Genomic and cDNA Cloning:  In order to obtain com-
plete genomic sequence coverage of cCRX, forward consen-
sus primer crx12 from exon I was used in combination with
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Figure 1. Genomic organization of cCRX.  The location of gene specific and vector (*) primers used in cDNA and genomic cloning and
characterization is indicated. The location of other CRX primers included in Table 1 are also indicated. Boxes identify exons (open denote 5'
and 3' UTR, shaded ORF); lines indicate introns.
TABLE 1. PRIMERS USED FOR CLONING CANINE CRX AND FOR
RADIATION HYBRID MAPPING
Sequence                   Primer ID   Primer Location
------------------------   ---------   -------------------
CAGCTTGGTGCATCAGATCCACG    crx-3       Exon I R' primer
GGTGGCTCTGAAGATCAACCTACC   crx-6       Exon II F' primer
GCAGGACGAGCCTTGGTCTGTGC    crx-7       Exon III R' primer
CTACAAGATCTGAAACTTCCAGG    crx-8       Exon III R' primer
CATGATGGCGTATATGAACCCG     crx-12      Exon I F' primer
TTGCCAGCCACACCTGCTGG       crx-13      Intron II F' primer
TCCGTCTAGGTCTCATTGAAGG     crx-14      Intron II R' primer
CAGCTCCACGGATGTAACCCC      crx-15      Intron II F' primer
GCTCAACCGTTGAGCCATCCAG     crx-16      Intron I F' primer
GGGGTTACATCCGTGGAGCTG      crx-18      Intron II R' primer
GGATGGCTCAACGGTTGAGCATC    crx-19      Intron I R' primer
CGGCACGAGGGACTCTGACTC      crx-20      5'UTR primer
GGAACCATGGAGGATACTTCGGG    crx-21      Intron II F' primer
TACCGAGCTCGGATCCACTA       pCRII-1     Vector primer
TTAAGCGGGATATCACTCAGC      T7          Vector primer
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consensus reverse primer crx-8 from exon III in a PCR reac-
tion on 100 ng of genomic DNA. (Figure 1). The resulting
PCR product was purified using the QiaexII gel extraction kit
(Qiagen, Chatsworth, CA), and cloned using the TA Cloning
kit (Invitrogen, San Diego, CA). Vector primers T7 and pcrII-
1 were used to obtain the 5' and 3' sequences of the genomic
clone. Exonic primers designed from consensus sequences
were used to sequence the CRX clone in order to establish
intron sizes; intronic primers were designed from the canine
clone sequence to give full genomic sequence coverage of
CRX. In order to obtain 5’UTR sequence, exon I reverse primer
crx-3 was used with vector primer pBK-III in a PCR reaction
with DNA extracted from a custom canine retinal cDNA li-
brary (Stratagene, La Jolla, CA). The resulting PCR product
was cloned (as above) and sequenced using vector specific
primers. Sequencing in an Applied Biosystems ABI 377 auto-
mated DNA sequencer at the core sequencing facility of Cornell
University verified the authenticity of the CRX clones. Table
1 gives details on primer sequences and PCR conditions used
for genomic cloning of cCRX.
Radiation hybrid (RH) mapping:  Exonic consensus prim-
ers were designed from CRX cDNA sequences available in
GenBank for mouse, rat, bovine, and human. A forward primer
(crx-6) from exon II was used in a canine genomic PCR reac-
tion with a reverse primer (crx-7) designed from exon III. The
resulting PCR product of 1200 nucleotides was purified using
the QiaexII gel extraction kit, eluted in water, and sequenced
using the crx-6 primer in the sequencing reaction. From the
resulting sequence, two intronic primers from intron II, crx-
13 and crx-14, were designed to produce a canine specific
PCR product of 174 base pairs (Table 1). The crx-13 and crx-
14 primers were tested on canine, hamster, and 5:1 hamster/
canine DNA under universal conditions (94 °C (20 s), 58 °C
(20 s), 74 °C (20 s); 30 cycles, 2.0 mM Mg2+, DNA 50 ng/µl)
[25] for use on a whole genome dog/hamster RH3000 panel
(92 RH cell RH083000, Research Genetics, Inc., Huntsville,
AL). To establish linkage to CFA1, we amplified five markers
(VASP, FH2634, C5RI, LHB and FH2326) previously pub-
lished for the region of interest [26]. In addition we used prim-
ers FH3505-f (5' ACTGGCCAAAGAGTACAAGG 3') and
FH3505-r (5' AGTCATGCTGATTTCTGTGC 3') to add
marker FH3505 to the canine RH map. The map was con-
structed using Multimap software [27] based on best two point
analysis, placing markers at Lod score 2.0 for overall order.
RESULTS
Isolation and characterization of cCRX cDNA by RDA and
library screening:  The different cDNA fragments obtained
from RDA/PCR amplification of mRNAs from normal and
cd dog retinas were subcloned into the pCR II cloning vector
(Invitrogen). Through sequence analysis and Genbank data-
base search, one of these fragments was found to have a high
degree of identity to the published human and mouse CRX
cDNA. This fragment was subsequently used to screen ap-
proximately 100,000 plaques from a custom made canine reti-
nal cDNA library (Stratagene). Two positive clones were iden-
tified, containing insert sizes of 2.2 and 3.4 kb. The longer
insert contained the entire sequence of the canine CRX cDNA
with an unusually long 3' untranslated region (UTR) of 2297
bp, 102 bp of the 5' UTR, as well as the open reading frame of
900 bp encoding a protein of 299 amino acids. This sequence
is similar to that obtained by cDNA library screening and clon-
ing. The complete cCRX cDNA sequence was compiled by
overlaying sequence data from the two different strategies used,
and the contig represented consensus sequence information
(GenBank accession number AF454668). Alignment of amino
acid sequences of cCRX with those of bovine, human, rat and
mouse showed a high degree of homology between these spe-
cies with complete conservation of the homeodomain (Figure
2).
Characterization of genomic cCRX:  Determination of
the genomic organization of the canine CRX gene was done
by PCR with primers designed from the canine sequence (Table
1). The positions of the exon and intron splice junctions, and
the primers used are shown in Figure 1. Comparative analysis
of the cCRX genomic and cDNA sequences revealed that the
gene structure consists of three exons and two introns. The 5'-
UTR and protein initiation codon as well as amino acids 2-34
are found in exon 1. Exon 2 contains the cDNA sequence en-
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Figure 2. CRX sequence comparisons.  A: The deduced amino acid
sequences of canine CRX and comparison with other species; the
conserved homeodomain is underlined. B: Canine CRX shows a high
degree of homology at the nucleotide and amino acid levels with
other species.
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coding 50 aa residues from 35 to 84. Exon 3 spans the remain-
ing 215 aa, and contains the entire 3'-UTR sequence. The sizes
of the two introns are 789 and 1059 bp, respectively.
Radiation hybrid mapping:  RH mapping using the
RH083000 canine-hamster panel placed cCRX on the
telomeric end of CFA1, in a position approximately 113.6
cR3000 telomeric to the tetranucleotide microsatellite FH2326,
and 31.7 cR3000 centromeric to the tetranucleotide
microsatellite FH2634 (Figure 3). Even though CRX and
marker FH3505 have not been previously mapped in the dog,
our RH3000 map is in complete agreement with the most re-
cent publication of the CNRS RHDF5000 canine radiation
hybrid map [28]. This region exhibits conserved synteny with
HSA19q13-q13.3, and is thus in accord with human mapping
data which localizes CRX to HSA19q13.
Evaluation of cCRX as a candidate for inherited photo-
receptor degeneration:  Cone degeneration in the Alaskan
malamute: The mapping of cCRX to CFA1 excluded this gene
as a candidate for cd. In other studies (Acland et al., unpub-
lished), we had previously observed multiple recombinations
between cd and markers FH2309, AHT138, C01.643, C01.164,
FH2326, and FH2294 which have been mapped to CFA 1 [28].
This effectively excludes the entire interval flanking cCRX
from association with the disease. In addition, northern blot
hybridization of a CRX cDNA probe to canine retinal RNA
from normal (16 weeks of age) and cd affected (6 weeks of
age) animals showed no detectable transcriptional differences
(data not shown).
rcd2 in the collie:  The sequence of the normal canine
CRX was compared to that of the rcd2 affected dogs. Full
length genomic clones and overlapping PCR products were
sequenced in both directions to provide full genomic cover-
age of the gene. No differences in the sequence were observed
between the normal and affected. Linkage analysis in an rcd2
pedigree informative for FH2634 demonstrated 2 recombi-
nants among 4 informative dogs in a phase known pedigree
(Figure 4A). The normal genomic sequencing and identifica-
tion of 2 of 4 recombinations in a marker physically proxi-
mate to CRX effectively rules out the gene from causal asso-
ciation with the disease.
Early onset retinal degeneration in the American Stafford-
shire terrier:  Genomic analysis indicated no sequence differ-
ences between normal and affected American Staffordshire
terriers. Microsatellites FH2326 and FH2634 were informa-
tive for linkage analysis in the pedigree. These markers flank
CRX and are tightly linked to each other with no recombina-
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Figure 3. Radiation hybrid mapping of cCRX on the whole genome
dog/hamster RH3000 panel.  The gene is mapped to the centromeric
part of CFA1 in a region of conserved synteny with HSA19q13-q13.3
(human cytogenetic position of gene markers is indicated in the right
panel). Tetranucleotide markers FH2326 and FH2634 used for link-
age analysis are shown in bold.
Figure 4. Linkage analysis in disease pedigrees.  A: Linkage of
FH2634 in an rcd2 informative pedigree. The different alleles are
shown below the gel for each, and the two recombinant animals (r)
identified. B: Linkage analysis of microsatellites FH2326 and FH2634
in an American Staffordshire terrier pedigree informative for early
onset retinal degeneration. The different alleles are shown below the
gel for each, and the recombinant animals (r) identified. The same
animals (5, 6) are recombinant with both markers. Genotype of the
pedigrees: square=male; circle=female; open, half shaded,
shaded=normal, asymptomatic carrier, affected, respectively.
NA=non-affected animal with heterozygous or homozygous normal
genotype.
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tions. Identifying 2 recombinant animals in the small subset
pedigree effectively excludes CRX as the disease causing gene
(Figure 4B).
PRA in the Tibetan terrier:  The small number of animals
available for study did not constitute a pedigree that could be
used to examine for co-segregation between a polymorphism
within markers flanking CRX and the disease. As an alterna-
tive strategy, we used genomic sequencing of the cCRX gene
from a PRA affected Tibetan terrier, and compared the se-
quence obtained with that of normal. No differences were
found, indicating the presumptive exclusion of this gene.
DISCUSSION
In this study, we examined cCRX as a potential disease caus-
ing gene for inherited retinal disorders in the dog. Initially, we
isolated and characterized the cCRX cDNA, determined its
genomic structure and compared it with published mamma-
lian orthologs (GenBank accession numbers: AF154123,
AF024711, AF135838, NM_007770). Sequence comparison
revealed that the most divergent region of the CRX cDNAs is
in the 3'-UTR which is unusually long, and has several cyti-
dine rich (C-rich) segments.
Because CRX plays a critical role in early photoreceptor
development and differentiation, we evaluated it as a candi-
date gene in a set of canine early onset diseases. These affect
the rods and/or cones, and are phenotypically comparable to
those which occur in man and result from mutations in CRX
[1,6-10]. As part of a specific effort to identify potential can-
didates for canine cd, we isolated clones by cDNA represen-
tational difference analysis between age matched normal and
cd affected retinas. Among the clones isolated, we identified a
cCRX transcript. However, linkage data already in hand
(Acland et al., unpublished) which showed multiple recombi-
nations to markers located in regions flanking cCRX [28] ef-
fectively and formally excludes cd from this entire interval on
CFA1.
In addition, no abnormalities in the CRX sequence were
found by comparing the exon sequences of normal dogs with
those from dogs affected with rcd2 (collies), or early onset
forms of PRA (American Staffordshire terrier, Tibetan terrier).
This excludes coding and splicing mutations of CRX from
involvement in the disease, but does not formally exclude the
gene. However, by using markers close to CRX on CFA1 for
linkage analysis, the candidate gene was excluded by finding
multiple recombinants in the rcd2 and American Staffordshire
terrier pedigrees. As multiple other genes and loci are associ-
ated with early onset rod and/or cone disease (RetNet), the
exclusion of CRX from these four canine diseases is not sur-
prising. Now that resources for linkage and physical mapping
of disease traits are available for dogs [26,28,29], it will be
possible to use the disease informative pedigrees to carry out
genome wide scans. These will allow the use of comparative
genomic approaches to identify the disease causing genes and
mutations present in these important animal models.
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